Extremity fasciotomy for patients on extracorporeal membrane oxygenation is independently associated with inpatient mortality.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
09 2022
Historique:
received: 16 09 2020
revised: 11 02 2021
accepted: 19 02 2021
pubmed: 18 11 2021
medline: 30 8 2022
entrez: 17 11 2021
Statut: ppublish

Résumé

Extracorporeal membrane oxygenation (ECMO) maintains end-organ perfusion in critically ill patients with cardiac or respiratory failure; however, ECMO cannulation in the extremities has been associated with significant limb ischemia and risk of compartment syndrome. Current literature on ECMO and fasciotomies is limited to small single-center retrospective studies. This study aimed to (1) compare the incidence of postoperative outcomes and mortality in patients undergoing fasciotomy while on ECMO to those of non-fasciotomy ECMO patients, and (2) assess the difference in adjusted mortality risk between the two groups. We hypothesized that patients undergoing fasciotomy while on ECMO would have significantly higher odds of in-hospital mortality than non-fasciotomy ECMO patients after adjustment for perioperative variables. We conducted a retrospective review of NIS from January 1st, 2012-September 30, 2015 for all hospitalizations involving ECMO and stratified them into two cohorts based on whether they underwent fasciotomy after ECMO. Patient baseline characteristics, in-hospital procedures, and postoperative outcomes were compared between the two cohorts. Logistic regression was used to assess in-hospital mortality risk between the two cohorts adjusting for age, sex, Elixhauser score, and perioperative procedures and non-fasciotomy perioperative morbidity. There were 7,085 estimated eligible discharges between 2012 and 2015 identified, 149 (2.1%) of which underwent fasciotomy following ECMO. One hundred and thirteen of the 149 hospitalizations (77%) in the fasciotomy cohort resulted in in-hospital mortality, compared to 3,805 of the 6,936 (55%) in the non-fasciotomy cohort. There were no differences in rates of transfusion (p=0.290), length of stay (p=0.282), or discharge disposition (p=0.126) between the two cohorts. In the logistic regression model, the fasciotomy cohort had a higher odds of in-hospital mortality than non-fasciotomy cohort (OR, 2.5; 95% CI, 1.1-5.6). Operative treatment of acute compartment syndrome for patients on ECMO therapy is associated with significantly increased mortality and morbidity. Whether fasciotomy is a marker of sickness or represents a cause-and-effect relationship is unknown and future should investigate the role of non-operative treatment of compartment syndrome on mortality in this population. III; Prognostic.

Identifiants

pubmed: 34785372
pii: S1877-0568(21)00409-6
doi: 10.1016/j.otsr.2021.103144
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103144

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

Raj M Amin (RM)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Yash P Chaudhry (YP)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Sandesh S Rao (SS)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Varun Puvanesarajah (V)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Matthew J Best (MJ)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Eric Etchill (E)

Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Erik A Hasenboehler (EA)

Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: eahtrauma@icloud.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH